查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370920

静脉水合治疗市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按服务、按组件、按最终用途行业、按地区、竞争细分

Intravenous Hydration Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Service, By Component, By End-Use Industry, By Region, Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年全球静脉 (IV)水合治疗市场价值为 30.4 亿美元，预计在预测期内将出现显着增长，预计复合年增长率 (CAGR) 为 6.76%，预计到 2028 年将达到 44.9 亿美元.静脉(IV)水合疗法是一种医疗方法，涉及透过静脉将液体、电解质（有时还包括药物）直接输送到人的血液中。这种疗法通常用于解决脱水和各种医疗状况。

主要市场驱动因素

  • 1.手术数量的增加推动市场成长：全球静脉（IV）水化治疗市场的成长主要是由手术数量的增加所推动的。静脉水化疗法在手术介入之前、期间和之后为患者提供支持方面发挥着至关重要的作用。外科手术可能导致液体和电解质失衡，因此适当的水合和电解质管理对于成功的结果和患者的康復至关重要。静脉水化疗法可确保患者在手术前获得充足的水分，支持稳定的血压、最佳的器官功能和整体健康。在手术期间，静脉补液疗法有助于维持适当的水合水平和电解质平衡，并支持身体对手术压力和麻醉的反应。手术后，静脉水化疗法对于预防併发症、促进癒合过程和降低术后问题的风险至关重要。
市场概况
预测期 2024-2028
2022 年市场规模 30.4亿美元
2028 年市场规模 44.9亿美元
2023-2028 年复合年增长率 6.76%
成长最快的细分市场 皮肤护理
最大的市场 北美洲
  • 2.健康和表现增强推动市场成长：以健康和生活方式为导向的方法的兴起极大地促进了全球静脉（IV）水化治疗市场的成长。这一趋势涉及个人寻求静脉水化治疗，不仅是出于医疗原因，而且是为了整体健康、改善生活方式和优化表现。静脉水化疗法被定位为满足这些需求的解决方案。它提供了一种快速有效的方法来补充身体水分，这对于整体健康和最佳身体表现至关重要。运动员、健身爱好者和生活方式要求较高的个人采用静脉补水疗法来快速恢復水合水平、对抗疲劳并补充在剧烈体力活动中损失的必需电解质。对巅峰身体和认知表现的追求促使人们探索静脉水化疗法作为支持其目标的手段。根据个人需求量身定制的静脉注射治疗进一步吸引了那些寻求个人化解决方案以提高健康和表现的人。
  • 3.老化人口的成长推动市场成长：老化人口的成长是全球静脉（IV）水化治疗市场的重要驱动力。随着年龄的增长，人们对脱水和电解质失衡的敏感度增加，使得静脉补液疗法成为重要的医疗干预措施。老年人可能会感到口渴感减弱，导致液体摄取不足并增加脱水风险。静脉水化疗法可快速解决脱水问题，并有助于预防相关的健康併发症。随着年龄的增长，包括肾臟疾病、糖尿病和心血管疾病在内的慢性疾病变得更加普遍，通常会导致体液和电解质失衡，需要定期静脉补液治疗来控制症状和维持整体健康。老年人的医疗程序、手术和住院治疗也更加频繁，静脉补液疗法通常用于控制医疗干预造成的液体和电解质失衡。此外，老年人经常服用多种可能影响液体和电解质平衡的药物，这使得静脉水化疗法成为支持适当水化和最大限度减少药物相关副作用的宝贵工具。

主要市场挑战

  • 1.监管和法律考虑：监管和法律考虑对全球静脉 (IV) 水化治疗市场构成重大挑战。确保患者安全、维持品质标准以及遵守当地和国际医疗实践和医疗管理法规至关重要。进行静脉水化治疗的医疗保健提供者必须持有适当的许可证和认证，这可能涉及广泛的培训和教育。不同的司法管辖区有不同的要求，这可能会影响静脉注射治疗服务的可用性和可近性。
  • 2.公众认知和教育：公众认知和教育对全球静脉（IV）水化治疗市场提出了挑战。对静脉水化疗法的适当医学适应症的误解和缺乏认识可能会阻碍其负责任的使用。静脉水化治疗的医疗必要性与健康或生活方式使用之间的区别可能不清楚，导致治疗过度使用、使用不足或误用。公众的看法受到支持静脉水化疗法益处的科学证据的影响。对某些应用的临床研究和实证研究不足可能会导致怀疑或不确定性。
  • 3.医疗专业知识：医疗专业知识是全球静脉（IV）水化治疗市场的重大挑战。安全有效地管理静脉输液和营养物质需要专门的训练和技能。接受过静脉注射治疗培训的合格医疗保健从业人员的可用性可能会影响静脉注射水化治疗服务的可及性和品质。不同的医疗保健专业人士对静脉注射疗法的实践范围和法规各不相同，这可能会限制患者接受这些治疗。复杂的患者病例可能需要更高程度的专业知识来确定适当的静脉注射治疗方案。

主要市场趋势

  • 1.健康和生活方式使用的兴起：全球静脉 (IV)水合治疗市场的一个显着趋势是以健康和生活方式为导向的使用的兴起。这一趋势表明，人们寻求静脉注射补水疗法不仅是出于医疗原因，也是为了整体健康、改善生活方式和优化表现。静脉水化疗法被认为是维持整体健康的补充方法，符合人们对整体健康日益增长的兴趣。消费者，包括运动员和生活方式要求较高的消费者，纷纷透过静脉补水疗法来提高能量水平、消除疲劳并增强整体活力。静脉水化疗法提供的便利性和快速结果吸引了寻求立即恢復活力的忙碌人士。
  • 2.可客製化的治疗：静脉水化疗法提供者越来越多地提供根据个人需求和目标量身定制的可客製化治疗。这种个人化的方法允许患者根据具体要求调整液体和营养素的成分。可自订的静脉注射治疗选项符合个人寻求健康、性能增强和整体福祉的客製化解决方案的趋势。患者可以与医疗保健专业人员合作设计静脉注射疗法，以满足他们独特的健康和生活方式目标。

细分市场洞察

服务洞察： 2022 年，静脉 (IV)水合治疗市场以能量增强治疗为主，预计这一趋势将持续下去。这些治疗可以立即解决疲劳、精力不足和活力不足的问题。运动员和生活方式忙碌的个人转向能量增强静脉注射疗法，以提高他们的表现并快速补充必需的营养。对促进整体健康和改善生活方式的治疗的需求支持了能量增强静脉注射疗法的增长，预计该细分市场从 2023 年到 2030 年将经历最高的年复合成长率(CAGR)。

成分洞察： 2022 年，静脉 (IV)水合治疗市场由药物细分市场主导，预计将继续扩大。药物静脉水化疗法通常用于需要针对性介入的医疗状况。严重脱水、电解质失衡、营养缺乏或特定急性疾病的患者可受益于定製药物的静脉注射治疗

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球静脉 (IV)水合治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依服务分类（免疫增强剂、能量增强剂、皮肤护理、偏头痛、其他）
    • 按成分（药物、非药物）
    • 按最终用途行业（医院和诊所、健康中心和水疗中心、家庭保健、其他）
    • 按公司划分 (2022)
    • 按地区
  • 市场地图

第 6 章：北美静脉 (IV)水合治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 按最终用途行业
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲静脉 (IV)水合治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 按最终用途行业
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区静脉 (IV)水合治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 按最终用途行业
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第 9 章：南美洲静脉 (IV)水合治疗市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 按最终用途行业
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲静脉 (IV)水合治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按服务
    • 按组件
    • 按最终用途行业
    • 按国家/地区
  • MEA：国家分析
    • 南非 静脉 (IV)水合疗法
    • 沙乌地阿拉伯 静脉 (IV)水合疗法
    • 阿联酋静脉 (IV)水合疗法

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 最近的发展
  • 产品发布
  • 併购

第 13 章：大环境分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 公司概况
  • 产品与服务
  • 财务（上市公司）
  • 最近的发展
  • SWOT分析
    • Core IV Therapy, LLC
    • Cryojuvenate UK Ltd.
    • B. Braun Medical Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • NexGen Health Inc
    • JW Life Science Corporation
    • Amanta Healthcare Ltd
    • Baxter International Inc.
    • Drip Hydration Inc

第 16 章：策略建议

简介目录
Product Code: 17102

The Global Intravenous (IV) Hydration Therapy Market, valued at USD 3.04 Billion in 2022, is poised for remarkable growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 6.76% and expected to reach USD 4.49 Billion by 2028. Intravenous (IV) Hydration Therapy is a medical treatment involving the direct delivery of fluids, electrolytes, and sometimes medications into a person's bloodstream through a vein. This therapy is commonly utilized to address dehydration and various medical conditions.

Key Market Drivers

  • 1. Increasing Surgical Procedures Drive Market Growth: The growth of the global Intravenous (IV) hydration therapy market is primarily driven by the increasing number of surgical procedures. IV hydration therapy plays a vital role in supporting patients before, during, and after surgical interventions. Surgical procedures can lead to fluid and electrolyte imbalances, making proper hydration and electrolyte management crucial for successful outcomes and patient recovery. IV hydration therapy ensures that patients are adequately hydrated before surgery, supporting stable blood pressure, optimal organ function, and overall well-being. During surgery, IV hydration therapy helps maintain appropriate hydration levels and electrolyte balance, supporting the body's response to surgical stress and anesthesia. After surgery, IV hydration therapy is essential for preventing complications, facilitating the healing process, and reducing the risk of postoperative issues.
Market Overview
Forecast Period2024-2028
Market Size 2022USD 3.04 Billion
Market Size 2028USD 4.49 Billion
CAGR 2023-20286.76%
Fastest Growing SegmentSkin Care
Largest MarketNorth America
  • 2. Wellness and Performance Enhancement Drive Market Growth: The rise of wellness and lifestyle-oriented approaches has significantly contributed to the growth of the global Intravenous (IV) hydration therapy market. This trend involves individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. IV hydration therapy is positioned as a solution to address these needs. It offers a quick and efficient method to rehydrate the body, which is essential for overall well-being and optimal physical performance. Athletes, fitness enthusiasts, and individuals with demanding lifestyles turn to IV hydration therapy to rapidly restore hydration levels, combat fatigue, and replenish essential electrolytes lost during strenuous physical activity. The pursuit of peak physical and cognitive performance has led individuals to explore IV hydration therapy as a means to support their goals. Customizable IV treatments tailored to individual needs further appeal to those seeking personalized solutions for wellness and performance enhancement.
  • 3. Growing Aging Population Propels Market Growth: The increasing aging population is a significant driver of the global Intravenous (IV) hydration therapy market. As people age, their susceptibility to dehydration and electrolyte imbalances rises, making IV hydration therapy an essential medical intervention. Older adults may experience reduced thirst sensation, leading to inadequate fluid intake and an increased risk of dehydration. IV hydration therapy quickly addresses dehydration and helps prevent associated health complications. Chronic conditions, including kidney disease, diabetes, and cardiovascular disorders, become more prevalent with age, often leading to fluid and electrolyte imbalances that require regular IV hydration therapy for symptom management and overall health maintenance. Medical procedures, surgeries, and hospitalizations are also more frequent among older adults, with IV hydration therapy commonly used to manage fluid and electrolyte imbalances resulting from medical interventions. Additionally, older adults frequently take multiple medications that can affect fluid and electrolyte balance, making IV hydration therapy a valuable tool in supporting proper hydration and minimizing medication-related side effects.

Key Market Challenges

  • 1. Regulatory and Legal Considerations: Regulatory and legal considerations pose significant challenges to the global Intravenous (IV) hydration therapy market. Ensuring patient safety, maintaining quality standards, and adhering to local and international regulations governing medical practices and the administration of medical treatments are essential. Healthcare providers who administer IV hydration therapy must hold the appropriate licenses and certifications, which can involve extensive training and education. Different jurisdictions have varying requirements, which can affect the availability and accessibility of IV therapy services.
  • 2. Public Perception and Education: Public perception and education present challenges to the global Intravenous (IV) hydration therapy market. Misconceptions and lack of awareness about the appropriate medical indications for IV hydration therapy can hinder its responsible use. The distinction between medical necessity and wellness or lifestyle use of IV hydration therapy can be unclear, leading to overuse, underuse, or misuse of the treatment. Public perception is influenced by the availability of scientific evidence supporting the benefits of IV hydration therapy. Insufficient clinical studies and evidence-based research on certain applications can lead to skepticism or uncertainty.
  • 3. Medical Professional Expertise: Medical professional expertise is a significant challenge to the global Intravenous (IV) hydration therapy market. Administering IV fluids and nutrients safely and effectively requires specialized training and skills. The availability of qualified healthcare practitioners trained in IV therapy can impact the accessibility and quality of IV hydration therapy services. Different healthcare professions have varying scopes of practice and regulations regarding IV therapies, potentially restricting patient access to these treatments. Complex patient cases may require a higher level of expertise to determine appropriate IV therapy protocols.

Key Market Trends

  • 1. Rise of Wellness and Lifestyle Use: A notable trend in the global Intravenous (IV) Hydration Therapy market is the rise of wellness and lifestyle-oriented use. This trend sees individuals seeking IV hydration therapy not only for medical reasons but also for general wellness, lifestyle enhancement, and performance optimization. IV hydration therapy is perceived as a complementary approach to maintaining overall health, aligning with the growing interest in holistic well-being. Consumers, including athletes and those with demanding lifestyles, turn to IV hydration therapy to boost energy levels, recover from fatigue, and enhance overall vitality. The convenience and rapid results offered by IV hydration therapy appeal to busy individuals seeking immediate revitalization.
  • 2. Customizable Treatments: IV hydration therapy providers are increasingly offering customizable treatments tailored to individual needs and goals. This personalized approach allows patients to adjust the composition of fluids and nutrients based on specific requirements. Customizable IV therapy options align with the trend of individuals seeking tailored solutions for wellness, performance enhancement, and overall well-being. Patients can work with healthcare professionals to design IV treatments that address their unique health and lifestyle objectives.

Segmental Insights

Service Insights: In 2022, the Intravenous (IV) Hydration Therapy market was dominated by energy-boosting treatments, a trend predicted to continue. These treatments provide immediate solutions for fatigue, low energy levels, and vitality. Athletes and individuals with busy lifestyles turn to energy-boosting IV therapy to enhance their performance and quickly replenish essential nutrients. The demand for treatments that promote overall well-being and lifestyle enhancement supports the growth of energy-boosting IV therapy, with the segment projected to experience the highest compound annual growth rate (CAGR) from 2023 to 2030.

Component Insight: In 2022, the Intravenous (IV) Hydration Therapy market was dominated by the medicated segment, expected to continue expanding. Medicated IV hydration therapy is often employed for medical conditions requiring targeted interventions. Patients with severe dehydration, electrolyte imbalances, nutrient deficiencies, or specific acute illnesses benefit from IV therapy with tailored medications

and nutrients. Hospitals and clinical settings commonly use medicated IV therapy as part of standard medical protocols.

End-Use Industry Insights: In 2022, hospitals and clinics dominated the Intravenous (IV) Hydration Therapy market, expected to continue expanding. These healthcare settings provide a controlled and medically supervised environment for IV hydration therapy. Medical professionals, including doctors and nurses, are trained to assess patient needs and administer IV therapy safely. Hospitals and clinics offer comprehensive medical care, allowing IV hydration therapy to be integrated into overall patient treatment plans.

Regional Insights: The Asia Pacific region leads the Global Intravenous (IV) Hydration Therapy Market, with North America, particularly the United States and Canada, also playing a significant role. North America benefits from an advanced healthcare system, well-established healthcare facilities, and a health-conscious population. The prevalence of wellness trends and the pursuit of holistic health and performance optimization contribute to the popularity of IV therapy in this region.

Key Market Players

  • Core IV Therapy, LLC
  • Rejuvenated UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health Inc
  • JW Life Science Corporation
  • Amanta Healthcare Ltd
  • Baxter International Inc.
  • Drip Hydration Inc

Report Scope:

In this report, the Global Intravenous (IV) Hydration Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Hydration Therapy Market, By Service:

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Others

Intravenous (IV) Hydration Therapy Market, By Component:

  • Medicated
  • Non-medicated

Intravenous (IV) Hydration Therapy Market, By End-User:

  • Hospitals & Clinics
  • Wellness Centers & Spas
  • Home Healthcare
  • Others

Global Intravenous (IV) Hydration Therapy Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Hydration Therapy Market.

Available Customizations:

  • Global Intravenous (IV) Hydration Therapy Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intravenous (IV) Hydration Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others)
    • 5.2.2. By Component (Medicated, Non-medicated)
    • 5.2.3. By End-Use Industry (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
    • 5.2.4. By Company (2022)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Intravenous (IV) Hydration Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Component
    • 6.2.3. By End-Use Industry
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intravenous (IV) Hydration Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End-Use Industry
    • 6.3.2. Mexico Intravenous (IV) Hydration Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End-Use Industry
    • 6.3.3. Canada Intravenous (IV) Hydration Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End-Use Industry

7. Europe Intravenous (IV) Hydration Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Component
    • 7.2.3. By End-Use Industry
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End-Use Industry
    • 7.3.2. Germany Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End-Use Industry
    • 7.3.3. United Kingdom Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End-Use Industry
    • 7.3.4. Italy Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End-Use Industry
    • 7.3.5. Spain Intravenous (IV) Hydration Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End-Use Industry

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Component
    • 8.2.3. By End-Use Industry
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End-Use Industry
    • 8.3.2. India Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End-Use Industry
    • 8.3.3. South Korea Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End-Use Industry
    • 8.3.4. Japan Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End-Use Industry
    • 8.3.5. Australia Intravenous (IV) Hydration Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End-Use Industry

9. South America Intravenous (IV) Hydration Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Component
    • 9.2.3. By End-Use Industry
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Intravenous (IV) Hydration Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End-Use Industry
    • 9.3.2. Argentina Intravenous (IV) Hydration Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End-Use Industry
    • 9.3.3. Colombia Intravenous (IV) Hydration Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End-Use Industry

10. Middle East and Africa Intravenous (IV) Hydration Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Component
    • 10.2.3. By End-Use Industry
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Intravenous (IV) Hydration Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End-Use Industry
    • 10.3.2. Saudi Arabia Intravenous (IV) Hydration Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End-Use Industry
    • 10.3.3. UAE Intravenous (IV) Hydration Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By End-Use Industry

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Core IV Therapy, LLC
    • 15.6.2. Cryojuvenate UK Ltd.
    • 15.6.3. B. Braun Medical Inc.
    • 15.6.4. Otsuka Pharmaceutical Co., Ltd.
    • 15.6.5. NexGen Health Inc
    • 15.6.6. JW Life Science Corporation
    • 15.6.7. Amanta Healthcare Ltd
    • 15.6.8. Baxter International Inc.
    • 15.6.9. Drip Hydration Inc

16. Strategic Recommendations